Expert Review of Vaccines
Volume 21, 2022 - Issue 8
Open access
9,566
Views
4
CrossRef citations to date
0
Altmetric
Review
Dendritic cell vaccine as a potential strategy to end the COVID-19 pandemic. Why should it be Ex Vivo?
Jonny JonnyCellcure Center, Gatot Soebroto Central Army Hospital, Jakarta, IndonesiaCorrespondence[email protected]
https://orcid.org/0000-0002-8564-7430View further author information
, https://orcid.org/0000-0002-8564-7430View further author information
Terawan Agus PutrantoCellcure Center, Gatot Soebroto Central Army Hospital, Jakarta, IndonesiaView further author information
, Enda Cindylosa SitepuCellcure Center, Gatot Soebroto Central Army Hospital, Jakarta, Indonesiahttps://orcid.org/0000-0002-8112-7198View further author information
& Raoulian IrfonCellcure Center, Gatot Soebroto Central Army Hospital, Jakarta, IndonesiaView further author information
Pages 1111-1120
|
Received 29 Mar 2022, Accepted 18 May 2022, Published online: 26 May 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.